Current status and prospects of GREM1 research in cancer (Review)
Molecular and Clinical Oncology · 19.07.2023 · 19 (3)
DOI: 10.3892/mco.2023.2665 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 19.07.2023. Verfasst von Dantong Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, P.R. China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110000, P.R. China.
- Department of Oncology, General Hospital of Northern Theater Command, Jinzhou Medical University, Shenyang, Liaoning 121017, P.R. China.
- Department of Oncology, General Hospital of Northern Theater Command, China Medical University, Shenyang, Liaoning 110000, P.R. China.
Zitieren
APA
Zhu, D., Zhao, D., Wang, N., Cai, F., Jiang, M., & Zheng, Z. (2023). Current status and prospects of GREM1 research in cancer (Review). Molecular and Clinical Oncology, 19(3). https://doi.org/10.3892/mco.2023.2665
Vancouver
Zhu D, Zhao D, Wang N, Cai F, Jiang M, Zheng Z. Current status and prospects of GREM1 research in cancer (Review). Molecular and Clinical Oncology. 2023;19(3). doi:10.3892/mco.2023.2665
BibTeX
@article{Zhu2023,
author = {Zhu, Dantong and Zhao, Dong and Wang, Naixue and Cai, Fei and Jiang, Mingzhe and Zheng, Zhendong},
title = {Current status and prospects of GREM1 research in cancer (Review)},
journal = {Molecular and Clinical Oncology},
year = {2023},
volume = {19},
number = {3},
doi = {10.3892/mco.2023.2665}
}
EUVIMED